I liked this part: "We need revenue pure and simple".
Indeed we could look at it as a marketing exercise, sequencing activities and attempting to generate revenue at the earliest opportunity.
In which case the simple, discrete Gadolinium replacement would have been a priority as 'the' trial ground on YoY, leading to revenue and SP appreciation while waiting for the big developments. And resulting in getting the name out there, to pave the way for bigger things.
Instead, it seems like the long pole in the tent was the main focus, and quicker wins were missed. Which has seen us go from ~20c to the current SP, as there was nothing generating revenue, and only a cloud of vagueness upon which to speculate.
It is obviously a complex space. But doing an environment analysis, identifying opportunities and risks, should be part of Management101.
GLTAH.
- Forums
- ASX - By Stock
- IBX
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-39
-
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
-0.005(13.5%) |
Mkt cap ! $1.140M |
Open | High | Low | Value | Volume |
2.9¢ | 3.2¢ | 2.8¢ | $15.77K | 543.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 85232 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 15297 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 85232 | 0.029 |
1 | 100000 | 0.028 |
2 | 200000 | 0.027 |
1 | 175000 | 0.026 |
5 | 269308 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 15297 | 2 |
0.033 | 12200 | 1 |
0.034 | 66460 | 1 |
0.035 | 5154 | 2 |
0.037 | 1425 | 1 |
Last trade - 15.31pm 10/10/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online